CC Bio Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

CC Bio General Information

Description

Developer a therapeutic discovery methodology intended for diagnosing and treating microbiome-based diseases. The company uses bespoke and precise synthetic biology to engineer and edit the microbiome with surgical precision to eliminate microbiome-based disease in a potent, specific, and prophylactic fashion, enabling healthcare professionals to prevent patients from misdiagnosis and over-prescription of drugs.

Contact Information

Website
www.ccbio.co.uk
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • The Cambridge Partnership, Dorothy Hodgkin Building
  • Babraham Research Campus, Babraham
  • Cambridge CB22 3FH
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • The Cambridge Partnership, Dorothy Hodgkin Building
  • Babraham Research Campus, Babraham
  • Cambridge CB22 3FH
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CC Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 01-Mar-2024 Completed Pre-Clinical Trials
11. Accelerator/Incubator 01-Jan-2024 Completed Pre-Clinical Trials
10. Accelerator/Incubator 01-Jan-2024 Completed Pre-Clinical Trials
9. Accelerator/Incubator 01-Mar-2023 Completed Pre-Clinical Trials
8. Seed Round 25-Aug-2021 Completed Pre-Clinical Trials
7. Grant 01-Jun-2020 Completed Startup
6. Grant 01-Feb-2020 Completed Startup
5. Accelerator/Incubator 01-Jan-2020 Completed Startup
4. Accelerator/Incubator 25-Jun-2019 $89.1K Completed Startup
3. Grant 15-May-2019 $13K $89.1K Completed Startup
To view CC Bio’s complete valuation and funding history, request access »

CC Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Seed
Ordinary 500 $0.001382 $165.88 $165.88 1x $165.88 3.37%
Ordinary 1,234 $0.001382 $78.42 $78.42 1x $78.42 8.33%
To view CC Bio’s complete cap table history, request access »

CC Bio Patents

CC Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4247943-A1 Polypeptides for treatment of bacterial infections Pending 18-Nov-2020
US-20240066103-A1 Polypeptides for treatment of bacterial infections Pending 18-Nov-2020
WO-2022105998-A1 Polypeptides for treatment of bacterial infections Inactive 18-Nov-2020
EP-3965890-A1 Polypeptides for treatment of bacterial infections Pending 10-May-2019
GB-201906653-D0 Polypeptides for treatment of bacterial infections Inactive 10-May-2019 A61K38/47
To view CC Bio’s complete patent history, request access »

CC Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CC Bio Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accelerate@Babraham Accelerator/Incubator
BioIndustry Association Accelerator/Incubator
CMS Ventures Corporate Venture Capital Minority
Deep Science Ventures Venture Capital Minority
INCATE Accelerator/Incubator
You’re viewing 5 of 10 investors. Get the full list »

CC Bio FAQs

  • When was CC Bio founded?

    CC Bio was founded in 2018.

  • Where is CC Bio headquartered?

    CC Bio is headquartered in Cambridge, United Kingdom.

  • What is the size of CC Bio?

    CC Bio has 5 total employees.

  • What industry is CC Bio in?

    CC Bio’s primary industry is Biotechnology.

  • Is CC Bio a private or public company?

    CC Bio is a Private company.

  • What is CC Bio’s current revenue?

    The current revenue for CC Bio is .

  • How much funding has CC Bio raised over time?

    CC Bio has raised $1.37M.

  • Who are CC Bio’s investors?

    Accelerate@Babraham, BioIndustry Association, CMS Ventures, Deep Science Ventures, and INCATE are 5 of 10 investors who have invested in CC Bio.

  • When was CC Bio acquired?

    CC Bio was acquired on 01-Mar-2024.

  • Who acquired CC Bio?

    CC Bio was acquired by Precisio Biotix Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process